Should I buy or sell Envoy Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Envoy Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" COCH shares. View COCH analyst ratings or view top-rated stocks .

What is Envoy Medical's stock price target for 2024?

2 Wall Street research analysts have issued twelve-month target prices for Envoy Medical's stock. Their COCH share price targets range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 86.3% from the stock's current price. View analysts price targets for COCH or view top-rated stocks among Wall Street analysts .

How have COCH shares performed in 2024?

Envoy Medical's stock was trading at $1.8106 at the start of the year. Since then, COCH stock has increased by 77.8% and is now trading at $3.22. View the best growth stocks for 2024 here .

When is Envoy Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 21st 2024. View our COCH earnings forecast .

How were Envoy Medical's earnings last quarter?

Envoy Medical, Inc. (NASDAQ:COCH) announced its earnings results on Wednesday, May, 15th. The company reported ($0.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.13. The business had revenue of $0.06 million for the quarter, compared to analyst estimates of $0.08 million.

Who are Envoy Medical's major shareholders?

Envoy Medical's stock is owned by many different institutional and retail investors. Top institutional investors include WealthTrust Asset Management LLC (0.06%). View institutional ownership trends .

How do I buy shares of Envoy Medical?

Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:COCH

Envoy Medical (COCH) Stock Price, News & Analysis

→ Boost your retirement with these AI payouts (From InvestorPlace) (Ad)

Free COCH Stock Alerts

$3.24

+0.13 (+4.18%)

(As of 02:00 PM ET)

Compare

Today's Range: $3.00
▼
$3.59
50-Day Range: $2.88
▼
$7.60
52-Week Range: $0.75
▼
$11.72

Volume: 25,437 shs
Average Volume: 301,716 shs
Market Capitalization: $63.50 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.00

Envoy Medical MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 86.3% Upside
$6.00 Price Target
Short Interest: Healthy
0.37% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.96
Based on 7 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.80) to ($0.78) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.08 out of 5 stars

Medical Sector

571st out of 918 stocks

Surgical Appliances & Supplies Industry

13th out of 18 stocks

3.5

Analyst's Opinion

Consensus Rating
Envoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Envoy Medical has only been the subject of 1 research reports in the past 90 days.
Read more about Envoy Medical's stock forecast and price target.

5.0

Short Interest

Percentage of Shares Shorted
0.37% of the float of Envoy Medical has been sold short.
Short Interest Ratio / Days to Cover
Envoy Medical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Envoy Medical has recently decreased by 26.23%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Envoy Medical does not currently pay a dividend.
Dividend Growth
Envoy Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for COCH.

1.1

News and Social Media Coverage

News Sentiment
Envoy Medical has a news sentiment score of -0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Envoy Medical this week, compared to 2 articles on an average week.
Search Interest
Only 4 people have searched for COCH on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
MarketBeat Follows
2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Envoy Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.67% of the stock of Envoy Medical is held by insiders.
Percentage Held by Institutions
Only 8.59% of the stock of Envoy Medical is held by institutions.
Read more about Envoy Medical's insider trading history.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Envoy Medical are expected to grow in the coming year, from ($0.80) to ($0.78) per share.
Read more about Envoy Medical's valuation and earnings.

See Top Rated MarketRank™ Stocks Here

Ad Stansberry Research

Everybody laughed when he recommended Netflix

"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Click here to see how it could become the No. 1 investment of the next decade.

About Envoy Medical Stock (NASDAQ:COCH)

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

COCH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

COCH Stock News Headlines

May 19 at 8:11 AM | seekingalpha.com

Envoy Medical Is Pursuing Filling A Hearing Industry Void

May 16, 2024 | investorplace.com

COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024

May 15, 2024 | finance.yahoo.com

Envoy Medical Reports First Quarter 2024 Results

May 15, 2024 | globenewswire.com

Envoy Medical Reports First Quarter 2024 Results

May 14, 2024 | americanbankingnews.com

Envoy Medical (NASDAQ:COCH) Trading Down 2.8%

April 24, 2024 | finance.yahoo.com

Envoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024

April 21, 2024 | finance.yahoo.com

Envoy Medical, Inc. (COCH)

April 20, 2024 | prnewswire.com

ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

April 17, 2024 | msn.com

Envoy Medical (COCH) Price Target Increased by 25.00% to 5.10

April 17, 2024 | markets.businessinsider.com

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

April 15, 2024 | prnewswire.com

COCH LOSS ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

April 5, 2024 | markets.businessinsider.com

ROSEN, A LEADING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

April 3, 2024 | prnewswire.com

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

April 3, 2024 | finance.yahoo.com

Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

April 3, 2024 | globenewswire.com

Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

April 3, 2024 | markets.businessinsider.com

COCH Stock Earnings: Envoy Medical Beats EPS, Beats Revenue for Q4 2023

April 2, 2024 | globenewswire.com

Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

March 29, 2024 | stockhouse.com

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

March 26, 2024 | markets.businessinsider.com

ROSEN, LEADING INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

March 24, 2024 | prnewswire.com

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

March 20, 2024 | markets.businessinsider.com

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

March 17, 2024 | prnewswire.com

COCH INVESTOR ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

March 12, 2024 | globenewswire.com

Envoy Medical to Participate in the 36th Annual ROTH Conference

March 10, 2024 | markets.businessinsider.com

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

March 9, 2024 | prnewswire.com

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

See More Headlines

Company Calendar

Last Earnings: 5/15/2024
Today: 5/20/2024
Next Earnings (Estimated): 8/21/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: NASDAQ:COCH
CUSIP: N/A
CIK: 1840877
Web: www.envoymedical.com
Phone: 877-900-3277
Fax: N/A
Employees: 34
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $6.00
High Stock Price Target: $6.00
Low Stock Price Target: $6.00
Potential Upside/Downside: +92.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-29,910,000.00
Net Margins: N/A
Pretax Margin: -7,718.85%
Return on Equity: N/A
Return on Assets: -112.11%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.10
Quick Ratio: 0.82

Sales & Book Value

Annual Sales: $316,000.00
Price / Sales: 192.90
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.38) per share
Price / Book: -8.18

Miscellaneous

Outstanding Shares: 19,600,000
Free Float: 19,469,000
Market Cap: $60.96 million
Optionable: Not Optionable
Beta: 2.59

Key Executives

Mr. Brent T. Lucas Esq. (Age 41)
CEO & Director
Comp: $303.66k
Mr. David R. Wells (Age 62)
Chief Financial Officer
Comp: $283.77k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

COCH Stock Analysis - Frequently Asked Questions

Should I buy or sell Envoy Medical stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Envoy Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" COCH shares.
View COCH analyst ratings or view top-rated stocks.
What is Envoy Medical's stock price target for 2024?: 2 Wall Street research analysts have issued twelve-month target prices for Envoy Medical's stock. Their COCH share price targets range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 86.3% from the stock's current price.
View analysts price targets for COCH or view top-rated stocks among Wall Street analysts.
How have COCH shares performed in 2024?: Envoy Medical's stock was trading at $1.8106 at the start of the year. Since then, COCH stock has increased by 77.8% and is now trading at $3.22.
View the best growth stocks for 2024 here.
When is Envoy Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 21st 2024.
View our COCH earnings forecast.

How were Envoy Medical's earnings last quarter?: Envoy Medical, Inc. (NASDAQ:COCH) announced its earnings results on Wednesday, May, 15th. The company reported ($0.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.13. The business had revenue of $0.06 million for the quarter, compared to analyst estimates of $0.08 million.
Who are Envoy Medical's major shareholders?: Envoy Medical's stock is owned by many different institutional and retail investors. Top institutional investors include WealthTrust Asset Management LLC (0.06%).
View institutional ownership trends.
How do I buy shares of Envoy Medical?: Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:COCH) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Envoy Medical (COCH) Stock Price, News & Analysis

Envoy Medical MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Consensus Rating

Amount of Analyst Coverage

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Dividend Yield

Dividend Growth

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows